Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann, W. K. 1; Heil, G. 2; Zander, C. 1; Wiebe, S. 2; Ottmann, O. G. 1; Bergmann, L. 3; Hoeffken, K. 4; Fischer, J. T. 5; Knuth, A. 6; Kolbe, K. 7; Schmoll, H. J. 8; Langer, W. 9; Westerhausen, M. 10; Koelbel, C. B. 11; Hoelzer, D. 1; Ganser, A. 2
[Article] Annals of Hematology. 83(8):498-503, August 2004.

(Format: HTML, PDF)